Q-Line Biotech IPO Closing Today 25 May 2026: GMP Rs 102-108 Signals 29-31% Listing Gain, Apply Before 5 PM

May 25, 2026
Posted by: Neeraj Pandey
Category: IPO

The Q-Line Biotech IPO closes TODAY (25 May 2026) at 5 PM on NSE SME. This is the LAST day to apply. The Rs 214.48 crore issue, India’s largest SME IPO of 2026, carries a grey market premium of Rs 102 to Rs 108 as of 24 May per IPOji, indicating an expected listing price of Rs 445 to Rs 451 (29.7 to 31.5 percent above the Rs 343 upper band). Ace investor Vikas Vijaykumar Khemani invested Rs 14.94 crore in the pre-IPO placement at Rs 343, providing strong institutional validation. Allotment is on 26 May 2026. Listing is on 29 May 2026 on NSE SME.

Table of Contents

Q-Line Biotech IPO Final Day Details

CLOSE DATE: TODAY 25 May 2026, LAST DAY. Apply before 5 PM.
Open Date: 21 May 2026
Allotment Date: 26 May 2026 (TOMORROW)
Share Credit: 27 May 2026
Listing Date: 29 May 2026 on NSE SME
Price Band: Rs 326 to Rs 343 per share
Issue Size: Rs 214.48 crore (62,53,200 shares after pre-IPO placement reduction)
Face Value: Rs 10 per share
Lot Size: 800 shares
Minimum Retail: 800 shares (1 lot) = Rs 2,74,400 at upper band
Category Split: QIB 50%, NII 15%, Retail 35%
Registrar: Purva Sharegistry (India) Pvt. Ltd.
Lead Managers: Hem Securities Ltd. and Share India Capital Services Pvt. Ltd.
GMP (24 May): Rs 102 to Rs 108 | Expected listing: Rs 445-451 (+29.7% to +31.5% above upper band)
GMP high: Rs 110 (20 May 2026)

Track Q-Line Biotech IPO GMP and live subscription on the .

Why Q-Line Biotech IPO Has a Strong GMP of Rs 102-108

Q-Line Biotech is India’s largest SME IPO of 2026 by issue size at Rs 214.48 crore. The Rs 102-108 GMP reflects three strong demand signals: institutional pre-IPO backing from ace investor Vikas Khemani (Rs 14.94 crore at Rs 343, the upper band), pre-IPO placement totalling Rs 27.44 crore from notable entities including Calliope Capital Advisors (Rs 8 crore) and Sahastraa Advisors (Rs 1 crore), and the structural growth in India’s IVD diagnostics market post-COVID. GMP peaked at Rs 110 on 20 May before stabilising in the Rs 102-108 range, suggesting steady grey market demand rather than speculative momentum.

Tap to Access Best Research Pieces on Univest

About Q-Line Biotech: IVD Diagnostics With 150+ Clients

Q-Line Biotech Limited, incorporated in 2013, is an integrated In-Vitro Diagnostics (IVD) company manufacturing reagent formulations, diagnostic equipment, rapid test kits, pathology instruments and specialised diagnostics. The product portfolio covers haematology, POC testing, clinical chemistry, molecular diagnostics, ELISA, rapid tests and special diagnostics. The company has over 15 years of experience in the diagnostics industry and serves 150-plus national and international clients. It has entered technical collaborations with international companies for manufacturing certain reagents and equipment under licensed specifications.

Business: IVD diagnostics, reagents, rapid test kits, diagnostic equipment, pathology instruments
Clients: 150+ national and international clients
Pre-IPO anchor: Vikas Khemani (Rs 14.94 crore at Rs 343) + total pre-IPO Rs 27.44 crore

Use of IPO Proceeds

Working Capital: Rs 93.50 crore, scaling reagent manufacturing and IVD product distribution
Debt Repayment: Rs 90 crore, repayment or prepayment of bank borrowings
General Corporate Purposes: Balance of net proceeds

Apply for Q-Line Biotech IPO today before 5 PM, track on Univest

FAQs on Q-Line Biotech IPO

Is today the last day to apply for Q-Line Biotech IPO?

Ans. Yes. Q-Line Biotech IPO closes TODAY, 25 May 2026, at 5 PM. Apply via ASBA through your bank or UPI through your broker app before 5 PM today. Allotment is on 26 May 2026. Listing is on 29 May 2026 on NSE SME.

What is the Q-Line Biotech IPO GMP today?

Ans. Q-Line Biotech IPO GMP is Rs 102 to Rs 108 as of 24 May 2026. This indicates an expected listing price of Rs 445 to Rs 451, a potential gain of 29.7 to 31.5 percent above the upper band of Rs 343. GMP peaked at Rs 110 on 20 May. GMP is an unofficial indicator and not a guaranteed listing price.

Should I apply for Q-Line Biotech IPO on the last day?

Ans. Q-Line Biotech IPO has a strong GMP of Rs 102-108 and pre-IPO backing from ace investor Vikas Khemani at Rs 343 (upper band). The Rs 214.48 crore issue is India’s largest SME IPO of 2026. Minimum investment is Rs 2,74,400 (800 shares). Apply before 5 PM today. Consult a SEBI-registered advisor before applying.

Closing today IPO

Author: Neeraj Pandey

Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.